Critique of "Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality"

Pharmacotherapy. 2023 Mar;43(3):257-258. doi: 10.1002/phar.2773.

Authors

Qoua L Her¹, Neil Dhopeshwarkar², Timothy Feeney¹

Affiliations

¹ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
² Real World Evidence and Consulting, TriNetX, Cambridge, Massachusetts, USA.

PMID: 36915172
DOI: 10.1002/phar.2773

No abstract available

Publication types

Letter

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
Hospitalization
Humans
Pneumonia* / drug therapy

Substances

Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Antagonists